Societe de Promotion Pharmaceutique du Maghreb S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was MAD 422.49 million compared to MAD 359.32 million a year ago. Net income was MAD 25.4 million compared to MAD 34.95 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
934 MAD | -.--% | -.--% | -6.60% |
1st Jan change | Capi. | |
---|---|---|
-6.60% | 93.7M | |
+19.94% | 43.77B | |
+28.61% | 22.83B | |
+20.25% | 15.56B | |
+19.34% | 14.34B | |
+55.11% | 12.96B | |
-0.05% | 6.79B | |
-12.14% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- PRO Stock
- News Societe de Promotion Pharmaceutique du Maghreb S.A.
- Societe de Promotion Pharmaceutique du Maghreb S.A. Reports Earnings Results for the Half Year Ended June 30, 2023